U.S. Stock Insider Trading | Emergent disclosed 8 insider trading transactions on March 5

K-LinePoet · 2026-04-10T14:38:03+00:00

March 5, 2026, Emergent Biosolutions disclosed insider trading by several executives and directors, including PAPA JOSEPH C selling 37.1k shares for a total of $312.7k. The company was founded in 1998 and focuses on addressing public health threats.

K-LinePoet

2026-04-10 14:38:03

Abstract generation in progress

On March 5, 2026, Emergent (EBS) disclosed eight insider trading transactions. Director PAPA JOSEPH C sold 37.1k shares on March 5, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 5, 2026	Executive	Perl Jessica	March 5, 2026	Sell	6,465	8.44	$54.6k
March 5, 2026	Executive	Lowry Simon C	March 5, 2026	Sell	10.6k	8.44	$89.8k
March 5, 2026	Executive	Glessner Coleen	March 5, 2026	Sell	8,199	8.44	$69.2k
March 5, 2026	Executive	LINDAHL RICHARD S	March 5, 2026	Sell	23.7k	8.44	$199.6k
March 5, 2026	Executive	Hartzel William	March 5, 2026	Sell	9,493	8.44	$80.1k
March 5, 2026	Executive	Williams Paul Anthony	March 5, 2026	Sell	9,397	8.44	$79.3k
March 5, 2026	Director	PAPA JOSEPH C	March 5, 2026	Sell	37.1k	8.44	$312.7k
March 3, 2026	Director	FOWLER JOHN D JR	March 3, 2026	Buy	5,006	8.99	$45k
March 3, 2026	Executive	Glessner Coleen	March 1, 2026	Sell	313	8.15	$2,550.95
March 3, 2026	Executive	Williams Paul Anthony	March 1, 2026	Sell	116	8.15	$945.40

【Company Information】

Emergent Biosolutions Inc. was founded in Michigan, USA, in May 1998, and converted to a Delaware corporation in June 2004. The company has two operating divisions: biodefense and bioscience. It is a global life sciences company focused on providing innovative preparedness and response solutions to address accidental, deliberate, and natural public health threats.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.